Compliance, safety, and effectiveness of fixed-dose artesunate-amodiaquine for presumptive treatment of non-severe malaria in the context of home management of malaria in Madagascar

American Journal of Tropical Medicine and Hygiene

Volumn 86, Issue 2, 2012, Pages 203-210

  Ratsimbasoa, Arsène ^a,b   Ravony, Harintsoa ^a,b   Vonimpaisomihanta, Jeanne Aimée ^a,b   Raherinjafy, Rogelin ^a,b   Jahevitra, Martial ^a,c   Rapelanoro, Rabenja ^a,c   Rakotomanga, Jean De Dieu Marie ^a,c   Malvy, Denis ^a,d   Millet, Pascal ^a,d   Ménard, Didier ^a,e  

^a INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

^b MINISTÈRE DE LA SANTÉ   (Madagascar)

^c UNIVERSITY OF ANTANANARIVO   (Madagascar)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; COARSUCAM; HEMOGLOBIN; QUININE; UNCLASSIFIED DRUG;

ADVERSE OUTCOME; ARTICLE; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIARRHEA; DRUG EFFECT; DRUG FATALITY; DRUG SAFETY; FEMALE; FEVER; FOLLOW UP; HEALTH CARE PERSONNEL; HEMOGLOBIN BLOOD LEVEL; HOME CARE; HUMAN; INFANT; MADAGASCAR; MAJOR CLINICAL STUDY; MALARIA; MALE; PATIENT COMPLIANCE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; TREATMENT FAILURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

AMODIAQUINE; ANTIMALARIALS; ARTEMISININS; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MADAGASCAR; MALARIA, FALCIPARUM; MALE; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

ARTESUNATE;

EID: 84856982080     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2012.11-0047     Document Type: Article

References (27)

1. Snow RW, Guerra CA, Mutheu JJ, Hay SI, 2008. International funding for malaria control in relation to populations at risk of stable Plasmodium falciparum transmission. PLoS Med 5: e142.
2. Foster S, 1995. Treatment of malaria outside the formal health services. J TropMedHyg 98: 29-34.
3. Kager PA, 2002. Malaria control: constraints and opportunities. Trop Med Int Health 7: 1042-1046. (Pubitemid 36960252)
4. Moerman F, Lengeler C, Chimumbwa J, Talisuna A, Erhart A, Coosemans M, D'Alessandro U, 2003. The contribution of health-care services to a sound and sustainable malaria-control policy. Lancet Infect Dis 3: 99-102. (Pubitemid 36164206)
5. Wiseman V, Scott A, Conteh L, McElroy B, Stevens W, 2008. Determinants of provider choice for malaria treatment: experiences from The Gambia. Soc Sci Med 67: 487-496.
6. World Health Organization, 2004. Scaling Up Home-Based Management of Malaria: from Research to Implementation. Geneva:World Health Organization.
7. World Health Organization, 2005. The Roll Back Malaria Strategy for Improving Access to Treatment through Home Management of Malaria. Geneva: World Health Organization WHO/HTM/MAL/2005.1101.
8. Greenwood B, Marsh K, Snow R, 1991. Why do some African children develop severe malaria? Parasitol Today 7: 277-281. (Pubitemid 121007888)
9. D'Alessandro U, Talisuna A, Boelaert M, 2005. Editorial: Should artemisinin-based combination treatment be used in the home-based management of malaria? Trop Med Int Health 10: 1-2. (Pubitemid 40193679)
10. Ratsimbasoa A, Randrianarivelojosia M, Millet P, Soares JL, Rabarijaona L, Rakotoson B, Malvy D, Menard D, 2006. Use of pre-packaged chloroquine for the home management of presumed malaria in Malagasy children. Malar J 5: 79.
11. Andriantsoanirina V, Menard D, Tuseo L, Durand R, 2010. History and current status of Plasmodium falciparum antimalarial drug resistance in Madagascar. Scand J Infect Dis 42: 22-32.
12. Menard D,RatsimbasoaA,Randrianarivelojosia M,Rabarijaona LP, RaharimalalaL, DomarleO,RandrianasoloL, Randriamanantena A, Jahevitra M, Andriantsoanirina V, Rason MA, Raherinjafy R, Rakotomalala E, Tuseo L, Raveloson A, 2008. Assessment of the efficacy of antimalarial drugs recommended by the National Malaria Control Programme in Madagascar: up-dated baseline data from randomized and multi-site clinical trials. Malar J 7: 55.
13. Pagnoni F, 2009. Malaria treatment: no place like home. Trends Parasitol 25: 115-119.
14. Menard D, Barnadas C, Bouchier C, Henry-Halldin C, Gray LR, Ratsimbasoa A, Thonier V, Carod JF, Domarle O, Colin Y, Bertrand O, Picot J, King CL, Grimberg BT, Mercereau- Puijalon O, Zimmerman PA, 2010. Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc Natl Acad Sci USA 107: 5967-5971.
15. Barnes KI, Durrheim DN, Little F, Jackson A, Mehta U, Allen E, Dlamini SS, Tsoka J, Bredenkamp B, Mthembu DJ, White NJ, Sharp BL, 2005. Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med 2: e330.
16. Depoortere E, Guthmann JP, Sipilanyambe N, Nkandu E, Fermon F, Balkan S, Legros D, 2004. Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in the Maheba refugee settlement, Zambia. Trop Med Int Health 9: 62-67. (Pubitemid 38178013)
17. Depoortere E, Salvador ET, Stivanello E, Bisoffi Z, Guthmann JP, 2004. Adherence to a combination of artemether and lumefantrine (Coartem) in Kajo Keji, southern Sudan. Ann Trop Med Parasitol 98: 635-637. (Pubitemid 39215518)
18. World Health Organization, 2003. Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated falciparum Malaria. Geneva: World Health Organization.
19. World Health Organization, 1996. Management of Uncomplicated Malaria and the Use of Antimalarial Drugs for the Protection of Travellers: Report of an Informal Consultation (WHO/MAL/96). Geneva:World Health Organization.
20. Mangold KA, Manson RU, Koay ES, Stephens L, Regner M, Thomson RBJr, Peterson LR, Kaul KL, 2005. Real-time PCR for detection and identification of Plasmodium spp. J Clin Microbiol 43: 2435-2440. (Pubitemid 40656261)
21. Rakotonirina H, Barnadas C, Raherijafy R, Andrianantenaina H, RatsimbasoaA, Randrianasolo L, JahevitraM,Andriantsoanirina V, Menard D, 2008. Accuracy and reliability of malaria diagnostic techniques for guiding febrile outpatient treatment in malaria-endemic countries. Am J Trop Med Hyg 78: 217-221. (Pubitemid 351844553)
22. Cattamanchi A, Kyabayinze D, Hubbard A, Rosenthal PJ, Dorsey G, 2003. Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp. Am J Trop Med Hyg 68: 133-139. (Pubitemid 38240534)
23. Hopkins H, Talisuna A, Whitty CJ, Staedke SG, 2007. Impact of home-based management of malaria on health outcomes in Africa: a systematic review of the evidence. Malar J 6: 134.
24. Ajayi IO, Browne EN, Bateganya F, Yar D, Happi C, Falade CO, Gbotosho GO, Yusuf B, Boateng S, Mugittu K, Cousens S, Nanyunja M, Pagnoni F, 2008. Effectiveness of artemisinin-based combination therapy used in the context of home management of malaria: a report from three study sites in sub-Saharan Africa. Malar J 7: 190.
25. Faucher JF, Aubouy A, Adeothy A, Cottrell G, Doritchamou J, Gourmel B, Houze P, Kossou H, Amedome H, Massougbodji A, Cot M, Deloron P, 2009. Comparison of sulfadoxine-pyrimethamine, unsupervised artemether-lumefantrine, and unsupervised artesunate-amodiaquine fixed-dose formulation for uncomplicated Plasmodium falciparum malaria in Benin: a randomized effectiveness noninferiority trial. J Infect Dis 200: 57-65.
26. Ajayi IO, Browne EN, Garshong B, Bateganya F, Yusuf B, Agyei-Baffour P, Doamekpor L, Balyeku A, Munguti K, Cousens S, Pagnoni F, 2008. Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sites. Malar J 7: 6.
27. White NJ, 2004. Antimalarial drug resistance. J Clin Invest 113: 1084-1092. (Pubitemid 38544090)